How much dividend does Karo Pharma pay?
Over the past 12 months, Karo Pharma paid a dividend of 0.27 SEK . This corresponds to a dividend yield of about 0.45 %. For the coming 12 months, Karo Pharma is expected to pay a dividend of 0.4 SEK.
Karo Pharma Dividend 2024
Karo Pharma Dividend
0.01 SEK
Karo Pharma Dividend yield
0.45 %
Ticker
KARO.ST
ISIN
SE0007464888
WKN
A14YW4
How much dividend does Karo Pharma 2024 pay?
According to the latest status from August 2024, Karo Pharma paid a total of 0.01 SEK per share in dividends within the last 12 months. With the current Karo Pharma price of 60.7 SEK, this corresponds to a dividend yield of 0.02 %. A dividend is paid times per year.
| 0.45 % Dividend Yield | = |
|
Historical Karo Pharma Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 6/4/2018 | 0.3 |
| 6/12/2017 | 0.22 |
1
Karo Pharma dividend history and estimates SE0007464888 · A14YW4
In 2023, Karo Pharma paid a dividend amounting to 0.01 SEK. Dividend means that Karo Pharma distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Karo Pharma provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Karo Pharma’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Karo Pharma's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Karo Pharma Dividend History
| Date | Karo Pharma Dividend |
|---|---|
| 2026e | 0.98 undefined |
| 2025e | 0.4 undefined |
| 2024e | 0.15 undefined |
| 2023e | 0.01 undefined |
| 2022e | -0.15 undefined |
| 2018 | 0.27 undefined |
| 2017 | 0.19 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2002 | 0 SEK | 0 SEK |
| 2003 | 0 SEK | 0 SEK |
| 2004 | 0 SEK | 0 SEK |
| 2005 | 0 SEK | 0 SEK |
| 2006 | 0 SEK | 0 SEK |
| 2007 | 0 SEK | 0 SEK |
| 2008 | 0 SEK | 0 SEK |
| 2009 | 0 SEK | 0 SEK |
| 2010 | 0 SEK | 0 SEK |
| 2011 | 0 SEK | 0 SEK |
| 2012 | 0 SEK | 0 SEK |
| 2013 | 0 SEK | 0 SEK |
| 2014 | 0 SEK | 0 SEK |
| 2015 | 0 SEK | 0 SEK |
| 2016 | 0 SEK | 0 SEK |
| 2017 | 0.19 SEK | 0 SEK |
| 2018 | 0.27 SEK | 0 SEK |
| 2019 | 0 SEK | 0 SEK |
| 2020 | 0 SEK | 0 SEK |
| 2021 | 0 SEK | 0 SEK |
| 2022e | 0 SEK | -0.15 SEK |
| 2023e | 0 SEK | 0.01 SEK |
| 2024e | 0 SEK | 0.15 SEK |
| 2025e | 0 SEK | 0.4 SEK |
| 2026e | 0 SEK | 0.98 SEK |
Is the Karo Pharma Dividend Safe?
Karo Pharma has been increasing the dividend for 2 years.
Over the past 10 years, Karo Pharma has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of 0% for the current fiscal year.
Karo Pharma dividend payout ratio SE0007464888 · A14YW4
In 2023, Karo Pharma had a payout ratio of 55.23%. The payout ratio indicates the percentage of the company's profits that Karo Pharma distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Karo Pharma represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Karo Pharma could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Karo Pharma's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Karo Pharma Payout Ratio History
| Date | Karo Pharma Payout ratio |
|---|---|
| 2026e | 54.21 % |
| 2025e | 55 % |
| 2024e | 52.39 % |
| 2023e | 55.23 % |
| 2022e | 57.37 % |
| 2021 | 44.56 % |
| 2020 | 63.77 % |
| 2019 | 63.77 % |
| 2018 | 6.13 % |
| 2017 | 121.42 % |
| 2016 | 63.77 % |
| 2015 | 63.77 % |
| 2014 | 63.77 % |
| 2013 | 63.77 % |
| 2012 | 63.77 % |
| 2011 | 63.77 % |
| 2010 | 63.77 % |
| 2009 | 63.77 % |
| 2008 | 63.77 % |
| 2007 | 63.77 % |
| 2006 | 63.77 % |
| 2005 | 63.77 % |
| 2004 | 63.77 % |
| 2003 | 63.77 % |
| 2002 | 63.77 % |
| Payout ratio | |
|---|---|
| 2002 | 63.77 % |
| 2003 | 63.77 % |
| 2004 | 63.77 % |
| 2005 | 63.77 % |
| 2006 | 63.77 % |
| 2007 | 63.77 % |
| 2008 | 63.77 % |
| 2009 | 63.77 % |
| 2010 | 63.77 % |
| 2011 | 63.77 % |
| 2012 | 63.77 % |
| 2013 | 63.77 % |
| 2014 | 63.77 % |
| 2015 | 63.77 % |
| 2016 | 63.77 % |
| 2017 | 121.42 % |
| 2018 | 6.13 % |
| 2019 | 63.77 % |
| 2020 | 63.77 % |
| 2021 | 44.56 % |
| 2022e | 57.37 % |
| 2023e | 55.23 % |
| 2024e | 52.39 % |
| 2025e | 55 % |
| 2026e | 54.21 % |
Dividend Details
Understanding Karo Pharma's Dividend Distributions
Karo Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Karo Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Karo Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Karo Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Karo Pharma Aktienanalyse
What does Karo Pharma do?
Karo Pharma AB is a Swedish pharmaceutical company specializing in the manufacturing and distribution of over-the-counter drugs and health products. The company's history dates back to 1986 when it was founded as Karo Bioforskning. Over time, the company went through several restructurings and realignments until it finally became an independent company listed on the Stockholm Stock Exchange in 2017 under the name Karo Pharma AB. Karo Pharma's business model is based on a broad portfolio of over-the-counter drugs and health products tailored to the needs of consumers in different countries and for different indications. The product range includes pain relievers, cold remedies, medications for digestive disorders, and eye care products. In addition, the company also offers dietary supplements and other health products. Karo Pharma operates in three main segments: Consumer Healthcare, Prescription Pharmaceuticals, and Out-licensing. Consumer Healthcare focuses on over-the-counter drugs and health products for end consumers. Examples include VagiVital, a medication for the treatment of vaginal yeast infections, and MolluscumVital, a product for the removal of warts. In the Prescription Pharmaceuticals segment, Karo Pharma offers prescription drugs for specific indications, such as Eklira, used in the treatment of chronic obstructive pulmonary disease (COPD). The Out-licensing segment involves the licensing of products and technologies to other companies. Karo Pharma has a particular focus on the development of products based on natural active ingredients. For example, Prenoxdiazin, used for pain relief, is based on an extract from the root of peonies. Natural ingredients are preferred in the development of other products as well, to maximize their compatibility and effectiveness. Overall, Karo Pharma's portfolio includes more than 20 brands and over 100 products distributed in various countries. The company is headquartered in Stockholm and operates in several European countries, as well as in the United States and Canada. Karo Pharma emphasizes close collaboration with doctors and pharmacists to ensure that its products meet the needs of consumers optimally. In recent years, Karo Pharma has become the leading provider of over-the-counter drugs and health products in Scandinavia and now plans to expand its presence in other European countries. The company aims to strengthen its position as the leading provider of over-the-counter drugs and health products, with a focus on innovative and natural solutions, through a combination of organic growth and targeted acquisitions of companies with complementary products and technologies. Karo Pharma is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Karo Pharma stock
What is the dividend yield of Karo Pharma?
The current dividend yield of Karo Pharma is 0.45 %.
When does Karo Pharma pay dividends?
Karo Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Karo Pharma?
Karo Pharma paid dividends every year for the past 4 years.
What is the dividend of Karo Pharma?
For the upcoming 12 months, dividends amounting to 0.4 SEK are expected. This corresponds to a dividend yield of 0.66 %.
In which sector is Karo Pharma located?
Karo Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Karo Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Karo Pharma from 5/11/2018 amounting to 0.3 SEK, you needed to have the stock in your portfolio before the ex-date on 5/4/2018.
When did Karo Pharma pay the last dividend?
The last dividend was paid out on 5/11/2018.
What was the dividend of Karo Pharma in the year 2023?
In the year 2023, Karo Pharma distributed 0 SEK as dividends.
In which currency does Karo Pharma pay out the dividend?
The dividends of Karo Pharma are distributed in SEK.
Andere Kennzahlen von Karo Pharma
Our stock analysis for Karo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Karo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
